Contact|Site Map|Search

Sirtris is focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, such as Type 2 Diabetes. Our research focus is on modulating the sirtuins, a recently discovered class of enzymes involved in the aging process.

Sirtris, a GSK company www.gsk.com
+ 02.01.10 Sirtris Presented at the Keystone Symposia: New Insights into Healthspan and Diseases of Aging: From Molecular to Functional Senescence
+ 11.18.09 Sirtris Honored with Scrip Award for Biotech of the Year
+ 10.27.09 Sirtris presented at Boston Biotech R&D Conference
+ 09.29.09 Sirtris appoints two new members to its Scientific Advisory Board
+ 09.23.09 Sirtris presented at the Aging & Healthy Lifespan Conference
+ 09.22.09 Sirtris presented at the Metabolic Diseases Drug Discovery & Development Conference
+ 09.04.09 Sirtris publishes the first reported human SIRT3 crystal structure in The Journal of Biological Chemistry
+ 07.07.09 Sirtris makes two key appointments
+ 06.22.09 Sirtris honored with American Business Awards for Best Overall Company of the Year and Executive of the Year

Find information regarding our clinical trials and areas of research. Learn more

+ 04.13.10 Sirtris Presents at the Boston Business Development Conference
+ 04.15.10 Sirtris Presents at the Society for Biomolecular Sciences 16th Annual Conference & Exhibition: Advancing the Science of Drug Discovery

Visit Resveratrol
© 2008 Sirtris™ Pharmaceuticals All Rights Reserved. Terms of Use | Privacy Statement